69 related articles for article (PubMed ID: 21325960)
1. Colitis associated with active systemic lupus erythematosus successfully treated with rituximab.
Tayal V; Chiu YH; George E; Mane S
J Clin Rheumatol; 2011 Mar; 17(2):79-82. PubMed ID: 21325960
[TBL] [Abstract][Full Text] [Related]
2. [Systemic lupus erythematosus associated macrophage activation syndrome with neuropsychiatric symptoms: A report of 2 cases].
Luo ZJ; Wu JJ; Song Y; Mei CL; DU R
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1111-1117. PubMed ID: 38101797
[TBL] [Abstract][Full Text] [Related]
3. Rituximab as an effective add-on maintenance therapy for disease activities in childhood-onset systemic lupus erythematosus.
Lin TW; Lin YT; Hu YC; Yu HH; Chiang BL
Lupus Sci Med; 2024 Jan; 11(1):. PubMed ID: 38242722
[TBL] [Abstract][Full Text] [Related]
4. Necrotizing mesenteric vasculitis in systemic lupus erythematosus.
Lourenço MH; Silva AB; Sousa J; Oliveira H; Silva I; Costa M; Branco JC; Gonçalves MJ
ARP Rheumatol; 2024; 3(1):49-52. PubMed ID: 38558064
[TBL] [Abstract][Full Text] [Related]
5. Refractory autoimmune hemolytic anemia in a patient with systemic lupus erythematosus and ulcerative colitis: A case report.
Chen DX; Wu Y; Zhang SF; Yang XJ
World J Clin Cases; 2024 May; 12(13):2286-2292. PubMed ID: 38808337
[TBL] [Abstract][Full Text] [Related]
6. Lithium Toxicity - A Chameleon to Gastrointestinal Vasculitis as an Initial Presenter of Systemic Lupus Erythematosus.
Guru S; Behera A; Barik S; Sahu A
Int J Appl Basic Med Res; 2023; 13(1):53-55. PubMed ID: 37266532
[TBL] [Abstract][Full Text] [Related]
7. Recurrent Temporal Infections: The Link to Systemic Lupus Erythematosus.
Shuhardi SA; Mohamed Said MS; Kew TY; Ramli R
Am J Case Rep; 2023 Dec; 24():e942163. PubMed ID: 38155491
[TBL] [Abstract][Full Text] [Related]
8. Rapid and Remarkable Response to Rituximab in a Case of Lupus Enteritis: Challenging the Norm.
Hussein AH; Altamimi BL
Mediterr J Rheumatol; 2024 Mar; 35(1):187-191. PubMed ID: 38855032
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal lung involvement of systemic lupus erythematosus-related vasculitis and alveolar proteinosis-like reaction.
Suzuki T; Enomoto N; Horiike Y; Asada K; Shirai T; Suda T
Respirol Case Rep; 2020 Jul; 8(5):e00559. PubMed ID: 32313654
[TBL] [Abstract][Full Text] [Related]
10. Cytokine Release Syndrome-Associated Colitis: Insights From a Case of Rituximab-Induced Pancolitis.
Vikash F; Vikash S; Mintz M; Elshafey S; Kim D; Wan D
ACG Case Rep J; 2024 Feb; 11(2):e01274. PubMed ID: 38371469
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory bowel disease and lupus: a systematic review of the literature.
Katsanos KH; Voulgari PV; Tsianos EV
J Crohns Colitis; 2012 Aug; 6(7):735-42. PubMed ID: 22504032
[TBL] [Abstract][Full Text] [Related]
12. Rituximab-associated colitis.
Bhalme M; Hayes S; Norton A; Lal S; Chinoy H; Paine P
Inflamm Bowel Dis; 2013 Mar; 19(3):E41-3. PubMed ID: 22488947
[No Abstract] [Full Text] [Related]
13. Systemic lupus erythematosus with inflammatory bowel disease-ulcerative colitis: case report.
Mansour HE; Arafa SG; Shehata WA
Lupus; 2018 Jun; 27(7):1198-1201. PubMed ID: 29320975
[TBL] [Abstract][Full Text] [Related]
14. Does inflammatory bowel disease coexist with systemic lupus erythematosus?
Shor DB; Dahan S; Comaneshter D; Cohen AD; Amital H
Autoimmun Rev; 2016 Nov; 15(11):1034-1037. PubMed ID: 27481039
[TBL] [Abstract][Full Text] [Related]
15. Ocrelizumab-induced inflammatory bowel disease-like illness characterized by esophagitis and colitis.
Barnes A; Hofmann D; Hall LA; Klebe S; Mountifield R
Ann Gastroenterol; 2021; 34(3):447-448. PubMed ID: 33948072
[TBL] [Abstract][Full Text] [Related]
16. Long-term endoscopic remission in Crohn's disease after allogeneic hematopoietic stem cell transplantation for diffuse large B cell lymphoma: case report and literature review.
Inomata Y; Kuroha M; Handa T; Shimoyama Y; Moroi R; Shiga H; Kakuta Y; Ichikawa S; Fukuhara N; Sato Y; Takahashi T; Masamune A
Clin J Gastroenterol; 2021 Aug; 14(4):1108-1114. PubMed ID: 33786703
[TBL] [Abstract][Full Text] [Related]
17. B lymphocytes, the gastrointestinal tract and autoimmunity.
Zouali M
Autoimmun Rev; 2021 Apr; 20(4):102777. PubMed ID: 33609796
[TBL] [Abstract][Full Text] [Related]
18. Ocrelizumab-Induced Severe Colitis.
Lee HH; Sritharan N; Bermingham D; Strey G
Case Rep Gastrointest Med; 2020; 2020():8858378. PubMed ID: 33354373
[TBL] [Abstract][Full Text] [Related]
19. Clinical Features of Rituximab-associated Gastrointestinal Toxicities.
Mallepally N; Abu-Sbeih H; Ahmed O; Chen E; Shafi MA; Neelapu SS; Wang Y
Am J Clin Oncol; 2019 Jun; 42(6):539-545. PubMed ID: 31136371
[TBL] [Abstract][Full Text] [Related]
20. De Novo Colitis Associated With Rituximab in 21 Patients at a Tertiary Center.
Eckmann JD; Chedid V; Quinn KP; Bonthu N; Nehra V; Raffals LE
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):252-253. PubMed ID: 30905719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
